Projects funded by the NCN
Identification of molecular mechanism of Escherichia coli response to antimicrobial blue light inactivation by genome-wide analysis.
2020/36/C/NZ7/00061
Keywords:
antimicrobial blue light (aBL) Escherichia coli genome-wide analysis photodynamic inactivation
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_12: Prevention of human diseases
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny
woj. pomorskie
Principal investigator (from the host institution):
dr Aleksandra Rapacka-Zdończyk
Number of co-investigators in the project: 2
Call: SONATINA 4 - announced on 2019-12-16
Amount awarded: 955 008 PLN
Project start date (Y-m-d): 2020-12-01
Project end date (Y-m-d): 2023-11-30
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.